<html>
<head>
    <meta name="GENERATOR" content="Microsoft Visual Studio 6.0">
    <title>Biological Use Authorization</title>
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/ORA1.css"> -->
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/Ora_BlueTables.css"> -->
    <link rel="stylesheet" type="text/css" href="/OrPortal/Forms/Compliance/IBC/IBC.css">
    <!-- Get Database Subroutines -->
    
    <!-- End Get Database Subroutines -->
    <!-- #XXXinclude virtual = "/appAsp/Include/StringUtilities.asp" -->
    
    <style>
.OriginalValuesBorder {
    border:3px solid orange;margin-top:5px;
}
.OriginalValuesTitle {
    color:orange;
    font-weight:bold;
}
.highlight {
    background-color:lightyellow; 
    border:1px solid orange;
    padding:2px;
}
.SemiHighlight {
    color:orange;
}
.warning {
    background-color:#FFE4C4; 
    border:1px solid orange;
    padding:2px;
}

th, .thBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-weight:bold;
	font-family:verdana;
}
td, .tdBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-family:verdana;
}

.THLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
	font-weight:bold;
}
.TDLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
}

.THLine2 {
	color:navy;
	background:white;
	font-size:8pt;
	font-weight:bold;
}
.TDLine2 {
	color:navy;
	background:white
	font-size:8pt;
}


.GlobalTd {
	background:white;
	color:navy;
	font-size:9pt;
}
.hdg1 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}
.xxxhdg2 {
	background:white;
	color:brown;
	font-size:11pt;
	font-weight:bold;
}
.hdg2 {
	background:navy;
	color:white;
	font-size:11pt;
	font-weight:bold;
	margin:1px;
	border-width:1px;
	border-color:white;
	padding:2px;
}
.hdg3 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}


</style>
    <script>window.status='ORA Production Database';</script>
</head>
<body>
    <form action method="POST" id="form1" name="form1">
        <!-- Outer Table -->
        <table width="650" cellpadding="2" cellspacting="0" border="1">
            <tr>
                <td class="GlobalTd">
                    <script>window.status='ORA Production Database';</script><table width="100%" cellpadding="0" cellspacing="0" border="0px">
<tr>
<td>Protocol#: B-20180048<br><br><div class="hdg1" align="center">University of California, Riverside<br>Institutional Biosafety Committee (IBC)<br>Application for Biological Use Authorization Registration</div>
<br><div class="hdg2">A. INVESTIGATOR DATA</div>
<table border="0" cellpadding="1" cellspacing="1" width="100%">
<tr>   <th class="THBlue">Principal Investigator</th>   <td class="TDBlue">Sarjeet S. Gill</td>
<td rowspan="10">&#160;&#160;&#160;&#160;&#160;</td>   <th class="THBlue">Email</th>   <td class="TDBlue">sarjeet.gill@ucr.edu</td>
</tr>
<tr>   <th class="THBlue">Department</th>   <td class="TDBlue">Cell Biology Neuroscience</td>   <th class="THBlue">Phone</th>   <td class="TDBlue">(951)-827-4621</td>
</tr>
<tr>   <th class="THBlue">Project Start/End Date</th>   <td class="TDBlue">9/1/2009-6/30/2021</td>   <th class="THBlue">Fax</th>   <td class="TDBlue">(951)-827-3087</td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Project Title:</th>
</tr>
<tr>   <td class="TDBlue" colspan="5">Elucidating insect function</td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Related Funding Agency(ies) (add as many as apply, even if use of rDNA is identical for each project):</th>
</tr>
<tr>   <td class="TDBlue" colspan="5">NIH, CDC, UC</td>
</tr>
<tr><td colspan="5">&#160;</td></tr>
<tr>   <th class="THBlue" colspan="2">Additional Contact person and phone # (if not or in addition to the PI):</th>   <td class="TDBlue" colspan="2">Jianwu, x2-3547</td>
</tr>
</table>
<br><br><div class="hdg2">B. RESEARCH LOCATIONS</div>
<table border="1" width="100%" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue" width="15%">Building &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Room #  &#160;&#160;&#160;</th>   <th class="THBlue" width="55%">List any containment facilities or equipment (biosafety cabinets, etc.) and their last certification dates. &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Certification<br>Date</th>
</tr>
<tr>   <td class="TDBlue">Biological Sciences&#160;&#160;&#160;</td>   <td class="TDBlue">3205C&#160;&#160;&#160;</td>   <td class="TDBlue">Isolated Mosquito Culture Room and Isolated Insect Chamber,&#160;&#160;&#160;</td>   <td class="TDBlue">3/13/2018&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Biological Sciences&#160;&#160;&#160;</td>   <td class="TDBlue">3205B&#160;&#160;&#160;</td>   <td class="TDBlue">Mosquito egg storage and insect incubator&#160;&#160;&#160;</td>   <td class="TDBlue">3/13/2018&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Biological Sciences&#160;&#160;&#160;</td>   <td class="TDBlue">3221&#160;&#160;&#160;</td>   <td class="TDBlue">Microscope room used for egg injections&#160;&#160;&#160;</td>   <td class="TDBlue">3/13/2018&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Biological Sciences&#160;&#160;&#160;</td>   <td class="TDBlue">3220, 3226, 3230&#160;&#160;&#160;</td>   <td class="TDBlue">Labs used for E. coli, Paraclostridiun bifermentans, Bacillus thuringiensis&#160;&#160;&#160;</td>   <td class="TDBlue">3/13/2018&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Biological Sciences&#160;&#160;&#160;</td>   <td class="TDBlue">3227&#160;&#160;&#160;</td>   <td class="TDBlue">Cell culture facility and storage of Botulinum toxin B catalytic domain&#160;&#160;&#160;</td>   <td class="TDBlue">3/13/2018&#160;&#160;&#160;</td>
</tr>
</table>
<br><br><div class="hdg2">C. PRIOR APPROVAL STATUS</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Application Type</th>   <td width="50%" class="TDBlue">Renewal</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, please list the number of the approved protocol</th>   <td class="TDBlue">BUA-2015006703</td>
</tr>
<tr>   <th class="THBlue">Does this project involve human or animal subjects, or a positive disclosure of a conflict of interest (income, loans, or management role in funding source, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has this project been reviewed by any other UCR review boards?  If so, indicate the relevant protocol numbers and approval dates:</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">IRB (human subjects)</th>   <td class="TDBlue">No</td>
</tr>
<tr>   <th class="THBlue">IACUC (animal subjects)</th>   <td class="TDBlue">A-20170005</td>
</tr>
<tr>   <th class="THBlue">Conflict of interest (provide approval date)</th>   <td class="TDBlue">Not applicable</td>
</tr>
<tr>   <th class="THBlue">Does this project involve strains of plant or animal pathogens not originating in California?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, CDFA and APHIS permits may be required.  List the relevant permit numbers and dates covered:</th>
</tr>
<tr>   <th class="THBlue">CDFA</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">APHIS</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Do experiments involve releasing organisms containing rDNA into the environment?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has an application for this release been filed with a state or federal regulatory agency?	Agency and date filed:</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Will you be using  a "Select Agent" (<a href="http://www.cdc.gov/od/ohs/lrsat.htm">www.cdc.gov/od/ohs/lrsat.htm</a>)</th>   <td class="TDBlue">True</td>
</tr>
</table>
<br><br><div class="hdg2">DESCRIPTION OF PROJECT</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Provide a brief, non-technical description and purpose of the project.</th>
</tr>
<tr>   <td class="TDBlue">The objective of the proposal is to determine basic physiology and biochemistry of insect species, both pest and non-pest. The longterm objective is to develop more effective means of controlling insect pests of humans and those in agriculture</td>
</tr>
<tr>   <th class="THBlue">What are the specific objectives of the work with biohazardous materials?</th>
</tr>
<tr>   <td class="TDBlue">The projects specific objectives are to determine the function of proteins involved in insect development, to identify bacterial toxin sequences, and to elucidate proteins involved in toxin interaction.  For functional studies some clones will be expressed in E coli, Bacillus thuringiensis, Bacillus megaterium, Paraclostridium bifermantans, Saccharomyces cerevisae, Drosophila melanogaster and Aedes aegypti.  Mutant Drosophila and Aedes will also be used for in vivo functional analysis.  For expression of clones in E coli, Bacillus, Paraclostridium, and Saccharomyces we use routine plasmid based transformation. 

One project involves the characterization of mechanisms of action of mosquito active toxins from Paraclostridium bifermentans.  These toxins are not toxic to vertebrates and most invertebrates.  We hypothesize they act on the nervous system of only specific mosquito species, for example Anopheles but not Aedes species. For these experiments we need to use a positive control that utilizes Botulinum neurotoxins A and B to cleave the human targets, which are expressed in E. coli and purified.  The amounts of Botulinum neurotoxins A and B needed are in ug amounts, and they are available commercially.   

For creating mutant Drosophila we use P-element based transformation and use mutant flies created by stock centers and other labs, including RNAi and UAS-GAL4 lines.  For creating mutant Aedes aegypti we will use two approaches.  The first is piggybac mediated transformation to drive genes under an inducible promoter (e.g. Aedes heat shock) or tissue specific promoters (e.g. an Aedes ALP expressed in larval gut); allowing the use of RNAi and UAS-GAL4 in Aedes. We also plan to use Crispr/Cas9 to label genes of interest; e.g. use one of GFP/CFP/Tomato to label the N- or C-terminus of genes of interest.  We also plan to use Crispr/Cas9 to knockout genes on interest.  None of the approaches used in my lab will result in gene drives.</td>
</tr>
</table>
<br><br><div class="hdg2">Potentially Biohazadous Materials</div>Please indicate yes or no if the following biohazardous materials are used currently within your laboratory or are proposed with the next year.  Please check all that apply.<table width="100%" border="0" cellpadding="0" cellspacing="0">
<tr>   <th colspan="2"><span class="hdg3">Human or Animal Infectious Agents</span></th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Prions</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Plant Infectious Agents</span>
</th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Other</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Recombinant DNA</span>
</th>
</tr>
<tr>   <th class="THLine1">Recombinant DNA in any form.</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Intentional release to the environment</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Transgenic Plants</span>
</th>
</tr>
<tr>   <th class="THLine1">Plants</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Liverworts</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Mosses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Algae</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Animals</span>
</th>
</tr>
<tr>   <th class="THLine1">Animals that are potential reservoirs of zoonotic diseases<br>(primates, wild animals, etc.)</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Infectious or hazardous agents in animals</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Human or primate cells in animals</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Transgenic animals</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Invertebrates</span>
</th>
</tr>
<tr>   <th class="THLine1">Exotic Arthropods</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Nematodes</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Intentional release to the environment</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Transgenic Insects</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Human Stem Cells</span>
</th>
</tr>
<tr>   <th class="THLine1">Human Stem Cells</th>   <td class="TDLine1">False</td>
</tr>
</table>
<br><div class="hdg2">Human or Animal Infectious Agents</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">List of Agents &#160;&#160;&#160;</th>   <th class="THBlue">Host of Range of Agent &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Bacillus thuringinesis, Bacillus megaterium, E.coli, Paraclostridium bifermentans, Saccharomyces cerevisae, and Botulinum neurotoxin A and B&#160;&#160;&#160;</td>   <td class="TDBlue">Human&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Are you using the wild-type of the agent?</th>   <td width="50%" class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Are you using genetically modified infectious agents (rDNA, mutagenesis, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe the agent and any potential safety issues.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Do the experiments have the potential to increase the host range of the agent?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Is the vector replication competent?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are you using fusion proteins or cell entry domains?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe any safety precautions you would recommend.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using human or primate blood, blood products, cells, cell lines or tissues</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#147;yes,&#148; please describe the blood, blood products, cells, cell lines or tissue and detail how the sample will be worked with during experimentation. Please include vendor information such as the ATCC number if available.</th>   <td class="TDBlue">Although we are not using these products we are getting all personnel who work with cell lines to undergo the Blood borne Pathogens Training.  Our use is only of fetal calf serum.</td>
</tr>
</table>
<br><div class="hdg2">Recombinant DNA</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">General features of the DNA &#160;&#160;&#160;</th>   <th class="THBlue">Species from which DNA originated &#160;&#160;&#160;</th>   <th class="THBlue">Species to receive DNA, type of vector, and transformation method &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Transporters, signaling and secretion molecules, receptors, reporter genes, binding proteins   &#160;&#160;&#160;</td>   <td class="TDBlue">Insects (mosquitoes, drosophila, lepidopterans), and vertebrates(mouse, rat)   &#160;&#160;&#160;</td>   <td class="TDBlue">Cultured insect (e.g. Sf21, C6/36) or mammalian cells (e.g. CHO, BHK). Transformation with lipofectin.&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Transporters, signaling and secretion molecules, receptors,  binding proteins   &#160;&#160;&#160;</td>   <td class="TDBlue">Aedes and Drosophila &#160;&#160;&#160;</td>   <td class="TDBlue">Aedes and Drosophila.  Transformation with  p-element or piggyBac vectors along with the appropriate transposase vector   &#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Reporter genes&#160;&#160;&#160;</td>   <td class="TDBlue">Cloned from jellyfish and modified to give other fluorescent proteins&#160;&#160;&#160;</td>   <td class="TDBlue">Aedes will be transformed by homologous recombination using Crispr/Cas9&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Knock out of genes  &#160;&#160;&#160;</td>   <td class="TDBlue">None&#160;&#160;&#160;</td>   <td class="TDBlue">Aedes aegypti using Crispr/Cas9&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">We also use of Botulinum neurotoxins A and B which are purchased commercially from List Biologicals&#160;&#160;&#160;</td>   <td class="TDBlue">N/A&#160;&#160;&#160;</td>   <td class="TDBlue">N/A&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Toxins, transporters, signaling and secretion molecules, receptors, reporter genes, binding proteins  &#160;&#160;&#160;</td>   <td class="TDBlue">Bacteria showing toxicity to insects (Bacillus thuringiensis, Paraclostrium bifermentans, Synthetic DNA).&#160;&#160;&#160;</td>   <td class="TDBlue">Into E. coli, Bacillus thuringiensis, Bacillus megaterium, Paralostridium bifermentans and Saccharomyces cerevisiae strains using appropriate vectors using chemical transformation or electroporation  &#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Will cultures of any recombinant organisms listed above exceed a volume of 10 liters?  </th>   <td width="50%" class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If so, where will the cultures be grown?</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Does your experiment involve the transfer of a drug resistance trait to any microorganism, plant, or insect that does not acquire that trait naturally?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe any potential environmental or health hazards of the experiments, including whether acquiring such a trait would compromise the use of the drug in medicine or agriculture.</th>   <td class="TDBlue">We are using resistance genes for selection in bacterila strains (E. coli, Bacillus and Clostridium) the lab.  None of the strains will be released to the environment and none should pose any health hazards.</td>
</tr>
<tr>   <th class="THBlue">Are you expressing genes encoding toxins with LD 50 less that 10 ng/kg of body weight?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the toxic product and safety precautions.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using hosts or vectors of rDNA (excluding E. coli K-12) that are viable pathogens of animals, plants, or microbes?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue">We are making transgenic Aedes mosquitoes that are vectors of human diseases.  However, none of the transgenic mosquitoes will be released to the environment, and none of the genes should make the mosquitoes better vectors.  The studies involve expressing dsRNA in vivo to attenuate gene function.\ or to label genes to analyze their expression.</td>
</tr>
<tr>   <th class="THBlue">Are you using recombinant DNA molecules containing the partial genome of any eukaryotic (plant or animal) virus?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the molecules, including genetic maps and the fraction of virus genome present, and safety precautions.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are your experiments likely to enhance the pathogenicity or extend the host range of a viral vector (e.g., introduction of novel control elements or a oncogene)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the hazards and safety precautions.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Will you be using genes involved in cell cycle control in animals (oncogene, tumor suppressor, cytokine, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the potential hazards.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Medical surveillance requirements or practices that you would recommend (antibody titering, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, list your recommendations in section 5.</th>   <td class="TDBlue"></td>
</tr>
</table>
<br><div class="hdg2">Invertebrates</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">List of Invertebrates &#160;&#160;&#160;</th>   <th class="THBlue">Range of Invertebrates &#160;&#160;&#160;</th>   <th class="THBlue">Exotic &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Drosophila, Aedes aegypti, Heliothis virescens&#160;&#160;&#160;</td>   <td class="TDBlue">All found in California&#160;&#160;&#160;</td>   <td class="TDBlue">No&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Is the organism an arthropod?</th>   <td width="50%" class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Does the arthropod belong to one of the following categories: D. melanogaster, Coleoptera, Lepidoptera, cockroaches and was purchased locally or collected from local populations?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Does the arthropod transmit pathogens of public health importance?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; then please list which ones.</th>   <td class="TDBlue">Aedes aegypti can transmit dengue, Zika and yellow fever if they are infected but we are not using any infected mosquitoes.</td>
</tr>
<tr>   <th class="THBlue">Is the arthropod regulated by USDA or USFWS?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please list any permits.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If the arthropod escaped would it be inviable or transient?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Is there active vector borne disease cycling?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Is the arthropod itself genetically engineered or does it now contain an engineered virus or endosymbiont.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Does the arthropod contain an engineered foreign, autonomous transposable element?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Are the mobility properties of the transposable element known?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Can the transposable element spread through the species?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Suggested level of biological containment.</th>   <td class="TDBlue">
<img src="/appAsp/images/CheckedBox.gif">ACL1 &#160;&#160;&#160;<img src="/appAsp/images/CheckBox.gif">ACL2 &#160;&#160;&#160;<img src="/appAsp/images/CheckBox.gif">ACL3 &#160;&#160;&#160;</td>
</tr>
</table>
<br><br><div class="hdg2">Define Controls</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue" width="50%">Do you need special equipment, engineering safeguards or personal protective equipment to maintain containment of your experiments (hoods, negative pressure rooms, gloves, etc.) </th>   <td class="TDBlue" width="50%">True</td>
</tr>
<tr>   <th class="THBlue"> If &#8220;yes&#8221;, list your recommendations.</th>   <td class="TDBlue">Biological Safety Cabinets.  We also have chemical hoods in the lab.  </td>
</tr>
<tr>   <th class="THBlue">Medical surveillance requirements or practices that you would recommend (antibody titering, etc.)? </th>   <td class="TDBlue">No</td>
</tr>
<tr>   <th class="THBlue">Suggested level of biological containment.</th>   <td class="TDBlue">BSL2</td>
</tr>
</table>
<br><div class="hdg2">Acknowledgement of Responsibilities</div>
<div class="tdBlue">For each of the elements below, please indicate if you will be following the UCR standard operating procedures and/or policies. If you indicate &#8220;yes&#8221; then you agree to and must follow the standard procedures and/or policies. If you answer &#8220;no,&#8221; please enter a brief description (in the space provided below the question) of the procedure you will follow and include a justification for deviating from the standard procedure and/or policy.</div>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Decontamination of biohazardous spills: I will used a 0.5 % sodium hypochlorite  (1:10 dilution of household bleach) to decontaminate equipment and work surfaces.  In locations where bleach would cause corrosion, I will decontaminate with an iodophor (e.g., Wescodyne).</th>   <td class="TDBlue" nowrap>True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue">Note we also have an SOP that was approved by EHS

We will use a 1:10 dilution of house hold bleach to decontaminate.  In addition the hoods are routinely UV irradiated.  Hoods will be recertified annually.</td>
</tr>
<tr>   <th class="THBlue">Storage: Biohazardous material will be clearly labeled with the universal biohazard symbol.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue">Biohazardous material will we labeled and use restricted to specific individuals.  Material will also be stored in the labeled refrigerators.  Botulinum neurotoxins A and B, purchased commercially  will be stored  in a locked refrigerator in the lab and be the responsibility of one individual in the lab.   </td>
</tr>
<tr>   <th class="THBlue">If I am using human or non-human primate blood or blood products, unfixed tissue, bodily fluids or organ or cell cultures of human origin, I will follow the exposure control plan for bloodborne pathogens.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue">If I am using human or non-human primate blood or blood products, unfixed tissue, bodily fluids or organ or cell cultures of human origin, I will follow the exposure control plan for blood borne pathogens.</td>
</tr>
<tr>   <th class="THBlue">All injuries and accidental inoculation, ingestion or inhalation of biohazardous material will be reported immediately to the lab director or supervisor and EH&amp;S (827-2648).  Dial 911 immediately for any medical emergency.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue">All injuries and accidental inoculations will be reported to EHS, and if a medical emergency is involved 911 will be dialed</td>
</tr>
<tr>   <th class="THBlue">All shipments of biological materials will follow university policy and all applicable federal and international regulations whenever shipped domestically or internationally.  Proper importation or exportation permits and licenses will be obtained before shipping or reviving biological materials to or from any international location.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue">All shipments of biological materials will follow university policy and all applicable federal and international regulations whenever shipped domestically or internationally. Proper importation or exportation permits and licenses will be obtained before shipping or reviving biological materials to or from any international location.</td>
</tr>
<tr>   <th class="THBlue">If I am generating medical and/or biohazardous waste, I will abide by the UC Riverside Medical and/or Biological waste plans.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue">If I am generating medical and/or biohazardous waste, I will abide by the UC Riverside Medical and/or Biological waste plans.</td>
</tr>
<tr>   <th class="THBlue">I understand that UC Riverside may be required by law to release a copy of this application to the public.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I understand that failure to comply with the applicable regulations governing the use of biohazardous materials described above may result in suspension of the authorization and might jeopardize any funding supporting the activities described herein.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I attest that I will conduct the study identified above in the manner described.  If I decide to make any changes in the procedure or if any problems occur which involve risk or the possibility of risk to others, I will immediately report such occurances or contemplated changes to the UCR Institutional Biosafety Committee, Research and Economic Development, 200 University Office Building, ext 2-4809; IBC@ucr.edu.</th>   <td class="TDBlue">True</td>
</tr>
</table>
<br><table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>______________________________</td>
<td>___________</td>
<td rowspan="2">&#160;&#160;&#160;&#160;</td>
<td>______________________________</td>
<td>___________</td>
</tr>
<tr>
<td>Principal Investigator</td>
<td>Date</td>
<td>Co-Investigator</td>
<td>Date</td>
</tr>
</table>
<br><em>Electronically signed and submitted to ORA on 10/24/2018 9:07:56 AM by <b>Sarjeet Gill</b></em><hr>IBC CERTIFICATION<div class="tdBlue">I certify that the Institutional Biosafety Committee has reviewed the proposed project.  In compliance with NIH guidelines and other specific NIH instructions, the project is (check one)<br><img src="/appAsp/images/CheckedBox.gif"> Approved as is.<br><img src="/appAsp/images/CheckBox.gif"> Approved with the following conditions:<br><br><br>
</div>
<table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>Level:	<img src="/appAsp/images/CheckBox.gif">BL1 &#160;&#160;<img src="/appAsp/images/CheckedBox.gif">BL2 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL3 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL4 &#160;&#160;</td>
<td>
<em>Electronically Signed by<br><u><b>Peter Atkinson</b></u></em> __________________________1/24/2019</td>
</tr>
<tr>
<td>&#160;</td>
<td>Chair-Institutional Biosafety Committee &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Date</td>
</tr>
</table>
                    <!-- End Outer Table -->
                </td>
            </tr>
        </table>
    
</td>
</tr>
</table>
</form>
</body>
</html>
